Baker Avenue Asset Management’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-93,320
| Closed | -$116K | – | 415 |
|
|
2024
Q2 | $116K | Buy |
93,320
+60,942
| +188% | +$75.6K | ﹤0.01% | 355 |
|
|
2024
Q1 | $61.2K | Hold |
32,378
| – | – | ﹤0.01% | 354 |
|
|
2023
Q4 | $85.5K | Hold |
32,378
| – | – | ﹤0.01% | 348 |
|
|
2023
Q3 | $74.5K | Hold |
32,378
| – | – | ﹤0.01% | 464 |
|
|
2023
Q2 | $118K | Buy |
32,378
+30,628
| +1,750% | +$112K | 0.01% | 405 |
|
|
2023
Q1 | $6.25K | Hold |
1,750
| – | – | ﹤0.01% | 835 |
|
|
2022
Q4 | $4.99K | Buy |
+1,750
| New | +$4.99K | ﹤0.01% | 817 |
|